Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Background No clinically proven effective antiviral strategy exists for the epidemic Coronavirus Disease 2019 (COVID-19). Methods We conducted a prospective, randomized, controlled, open-label...